arrow
J

John E. Dick

princess margaret hospital
H指数:107
被引数:6.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia

FATP2介导的脂质代谢增强了B细胞急性淋巴细胞白血病中嵌合抗原受体T细胞疗法的抗性

Leukemia
IF13.4
2026-06-300
OAAI
Human haematopoietic stem cells remember inflammatory stress

人类造血干细胞能够记忆炎症应激

Nature
IF48.5
2026-05-270
OAAI
Transposable elements shape stemness in normal and leukemic hematopoiesis

转座元件在正常和白血病造血中的形状

2026-05-040
OAAI
Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation

谷氧还蛋白2通过线粒体通透性转换孔调节对AML生存至关重要

Blood
IF23.1
2025-11-180
OAAI
Multipotent lineage potential in B cell acute lymphoblastic leukemia is associated with distinct cellular origins and clinical features

B细胞急性淋巴细胞白血病的多能谱系潜能与特定的细胞起源和临床特征相关。

2025-06-270
PRE
The Exportin, CSE1L, Regulates Ribosome Biogenesis and Is a Selective Dependency in Childhood and Young Adult Acute Myeloid Leukemia

Exportin CSE1L 调节核糖体生物发生,并且是儿童及年轻成人急性髓系白血病的选择性依赖。

BLOOD
IF23.1
2024-11-050
PRE
Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging

突变干细胞在人类克隆造血中的选择性优势与对炎症和衰老的反应减弱有关

2024-08-016
OAAI
Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance

急性髓性白血病的单细胞染色质可及性分析揭示了耐药后的异质性谱系组成

2023-07-216
OAAI
Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia

异二聚体细胞因子受体的不同组装控制白血病的Stemness程序

2023-05-166
OAAI
Simultaneous inhibition of Sirtuin 3 and cholesterol homeostasis targets acute myeloid leukemia stem cells by perturbing fatty acid β-oxidation and inducing lipotoxicity
2023-04-0619
OAAI
In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
2023-02-098
OAAI
KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition
LEUKEMIA
IF13.4
2023-01-319
OA
Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma
2022-09-2610
PRE